|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Revance Therapeutics (NASDAQ: RVNC) through any online brokerage.
The latest price target for Revance Therapeutics (NASDAQ: RVNC) was reported by Needham on October 18, 2021. The analyst firm set a price target for 25.00 expecting RVNC to rise to within 12 months (a possible 61.92% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $15.44 last updated Fri Oct 22 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Revance Therapeutics.
Revance Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.